Healthequity Inc (NASDAQ:HQY) – Equities researchers at KeyCorp lowered their Q4 2019 earnings estimates for shares of Healthequity in a research note issued on Tuesday, December 4th. KeyCorp analyst D. Hooker now anticipates that the company will earn $0.09 per share for the quarter, down from their prior forecast of $0.15. KeyCorp has a “Overweight” rating and a $105.00 price objective on the stock.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, December 4th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.02. Healthequity had a return on equity of 12.42% and a net margin of 24.52%. The business had revenue of $70.50 million during the quarter, compared to analyst estimates of $69.60 million. During the same period in the prior year, the company earned $0.17 earnings per share. Healthequity’s revenue was up 24.1% compared to the same quarter last year.

Several other equities analysts have also weighed in on HQY. Citigroup reissued a “buy” rating and set a $110.00 price objective on shares of Healthequity in a report on Wednesday, September 5th. Wells Fargo & Co increased their price objective on Healthequity from $84.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, September 5th. Cantor Fitzgerald increased their price objective on Healthequity from $68.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, September 5th. Oppenheimer increased their price objective on Healthequity from $85.00 to $104.00 and gave the company an “outperform” rating in a report on Wednesday, September 5th. Finally, SunTrust Banks increased their price objective on Healthequity to $105.00 and gave the company a “buy” rating in a report on Wednesday, September 5th. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $92.08.

Shares of NASDAQ HQY opened at $74.03 on Friday. Healthequity has a 1-year low of $42.92 and a 1-year high of $101.58. The firm has a market cap of $5.19 billion, a price-to-earnings ratio of 137.09, a PEG ratio of 2.90 and a beta of 1.37.

In other news, VP Darcy G. Mott sold 4,000 shares of the firm’s stock in a transaction on Tuesday, November 20th. The stock was sold at an average price of $76.91, for a total value of $307,640.00. Following the completion of the transaction, the vice president now directly owns 89,500 shares of the company’s stock, valued at $6,883,445. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold 12,000 shares of company stock valued at $1,027,400 over the last ninety days. Corporate insiders own 4.00% of the company’s stock.

Hedge funds have recently modified their holdings of the stock. Redwood Investments LLC bought a new position in shares of Healthequity during the 2nd quarter valued at about $12,188,000. Meeder Asset Management Inc. bought a new stake in Healthequity in the third quarter worth about $172,000. WINTON GROUP Ltd raised its position in Healthequity by 33.7% in the second quarter. WINTON GROUP Ltd now owns 4,557 shares of the company’s stock worth $342,000 after acquiring an additional 1,148 shares in the last quarter. Legal & General Group Plc raised its holdings in Healthequity by 7.7% during the 2nd quarter. Legal & General Group Plc now owns 114,642 shares of the company’s stock worth $8,683,000 after buying an additional 8,186 shares during the period. Finally, American International Group Inc. raised its holdings in Healthequity by 249.3% during the 3rd quarter. American International Group Inc. now owns 145,055 shares of the company’s stock worth $13,695,000 after buying an additional 103,527 shares during the period. Institutional investors own 93.01% of the company’s stock.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Read More: Return on Equity (ROE)

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.